Ipsen Biopharm Ltd. opposition analysis

COMPANY ANALYSIS

Latest patents of Ipsen Biopharm Ltd. opposed by its competitors

Patent:
Grant Date:
May 5, 2021
Title:
Combinations Of Liposomal Irinotecan, 5-Fu And Leucovorin For The Treatment Of Pancreatic Cancer
Oppositions:
3
Patent:
Grant Date:
Dec 9, 2020
Title:
Combination Therapy Using Liposomal Irinotecan And A Parp Inhibitor For Cancer Treatment
Oppositions:
1
Patent:
Grant Date:
Aug 12, 2020
Title:
Methods For Treating Metastatic Pancreatic Cancer Using Combination Therapies Comprising Liposomal Irinotecan And Oxaliplatin
Oppositions:
2
Patent:
Grant Date:
May 3, 2017
Title:
Methods For Treating Pancreatic Cancer Using Combination Therapies Comprising Liposomal Irinotecan
Oppositions:
1

Want to track Ipsen Biopharm Ltd.?

Feel free to send us a message here and we will get back to you